FILING ANALYSIS · TUESDAY, OCTOBER 27
aTYR PHARMA INC ATYR — 8-K: Amendments to Articles of Incorporation or Bylaws
neutral
The company is undergoing a 1-for-40 reverse stock split, which will reduce the number of outstanding shares from approximately 100.5 million to 2.5 million, affecting all stockholders proportionately and not changing percentage ownership, except for fractional shares which will be rounded up to whole shares.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →